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Inflammatory Myofibroblastic Tumor: 
a Possible Complication of Percutaneous
Radiofrequency Ablation for
Hepatocellular Carcinoma
An inflammatory myofibroblastic tumor (IMT) is an uncommon, benign lesion
characterized by the mesenchymal proliferation and infiltration of inflammatory
cells composed primarily of lymphocytes and plasma cells. A percutaneous
radiofrequency ablation (RFA) is an effective and safe therapeutic modality used
for the management of liver malignancies. Here we report, for the first time, a
case of IMT as a complication of RFA for hepatocellular carcinoma in a 61-year-
old man with a Child’s class A hepatitis B-related liver cirrhosis. Gastrohepatic fis-
tula formation was pathologically proven and associated with the RFA. Such a
longstanding inflammation of the fistula might have been a possible cause of the
development of IMT in this case. 
n inflammatory myofibroblastic tumor (IMT) is an uncommon, benign
lesion which may simulate a malignancy on imaging studies. It is charac-
terized by a mesenchymal proliferation featuring inflammatory cell
infiltrates composed primarily of lymphocytes and plasma cells. Its pathogenesis is
uncertain, although it is suggested that there are subsets of IMT with a neoplastic and
reactive nature (1, 2).
A percutaneous radiofrequency ablation (RFA) is the most extensively used local
ablation therapeutic modality for the management of primary or metastatic liver
malignancies. The increasing appeal for this technique is attributed to its effectiveness,
safety, and low morbidity rate (3). However, a number of potential major complica-
tions of an RFA have been described, occurring at a rate of 2%, including liver
abscess, subcapsular hematoma, biliary stricture, perforation of the gastrointestinal
tract and tumor seeding (4). Theoretically, an IMT could occur as a complication of an
RFA because of thermal and mechanical injury caused by an RFA, which can induce
an inflammatory change. However, until now, an IMT following an RFA has not been
reported. 
Herein, we report a case of an IMT involving a gastrohepatic ligament and adjacent
liver and stomach, which developed after an RFA accompanied with a gastrohepatic
fistula. To the best of our knowledge, this report is the first to present a case of an IMT
in association with an RFA.
CASE REPORT
In a 61-year-old man with Child’s class A hepatitis B-related liver cirrhosis, a 2.3 cm-
sized mass was detected in Couinaud’s segment III of the liver upon a routine screen-
ing US which was performed as a surveillance of the hepatocellular carcinoma (HCC)
(Fig. 1A). On a subsequent contrast-enhanced CT, the mass showed a typical enhance-
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Ament pattern consistent with HCC: subtle arterial enhance-
ment and delayed washout (Fig. 1B). The serum α -fetopro-
tein (α FP) concentration at that time was 1.4 ng/ml. The
mass was diagnosed as an HCC according to the 2005
guidelines of the American Association for the Study of
Liver Diseases (5).
The patient underwent a percutaneous RFA to treat the
tumor. The lesion was located peripherally and closely
abutted against the stomach. Therefore, 500 ml of artificial
ascites using dextrose 5% fluid was inserted between the
left lateral hepatic segment and the stomach to prevent
gastric thermal injury during the RFA. The tumor was
ablated using the switching monopolar RFA technique (6).
Three, 17-gauge, internally cooled electrodes with 3-cm
active tips (Cool Tip Electrode; Valleylab, Bouler, CO) and
a prototype multichannel RF generator (Taewong Medical
Co., Koyang, Kyungki, Korea) to allow automatic switch-
ing of RF energy among three electrodes according to their
impedance changes, were used to apply RF energy to the
tumor. The lesion was ablated in one session and the total
duration of ablation was 18 minutes at an average energy
of 28,040 calories. The patient was asymptomatic after the
procedure and was discharged the next day. Moreover, the
patient was well and asymptomatic following a one month
of routine outpatient follow-up.
The one-month follow-up CT images after the RFA (Fig.
1C, D) showed a thick-walled cystic change at the RFA site
suggesting coagulation necrosis with liquefaction. The
lesion closely abutted against the lesser curvature of the
stomach at which asymmetric and heterogeneous wall
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Fig. 1. 61-year-old man with 2.3 cm-sized hepatocellular carcinoma in segment III of liver. 
A. On sagittal US image, low echoic nodule (arrow) is seen in left lateral segment of liver. Note proximity of lesion to stomach (S). 
B. Contrast-enhanced CT images display well-demarcated lesion (arrows) showing subtle enhancement on arterial phase (left) and
washout of contrast material on portal venous phase (right).
C, D. Axial (C) and coronal reformatted (D) CT image obtained one month after radiofrequency ablation revealing thick-walled cyst-like
appearance (arrows) of radiofrequency ablation site. Asymmetric and heterogeneously enhancing wall thickening (arrowheads in D)
suggesting thermal injury is noted at adjacent lesser curvature of stomach. 
CDthickening suggesting a thermal injury and subsequent
chronic inflammation was shown (Fig. 1D). The patient did
not complain of any symptoms and no laboratory tests was
performed at that time.
The next routine follow-up CT at three months after the
RFA showed a collapse of the previously seen, thick-
walled, cystic lesion, and a newly appeared enhancing
mass near the RFA site (Fig. 1E-G). On a coronal reformat-
ted CT image obtained during the portal venous phase, the
mass extended exophytically and the extrahepatic portion
of the mass was in contact with the adjacent stomach and
compressed it (Fig. 1G). Contrast-enhanced dynamic CT
scans revealed that the mass enhanced slightly on both the
arterial and portal venous phase CT images (Fig. 1F).
Quantitatively, the attenuation of the mass was slightly
higher (100 HU versus 82 HU) than that of the normal
liver parenchyma on the arterial phase and with slightly
lower (104 HU versus 117 HU) than that of the normal
liver parenchyma on the portal venous phase. Transient
hepatic attenuation differences around the lesion and
infiltration around falciform ligament on arterial phase
were also noted. At the time of interpretation, a tentative
radiologic diagnosis was  a marginal recurrence of HCC
with suspicious gastric invasion.
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Fig. 1. 61-year-old man with 2.3 cm-sized hepatocellular carcinoma in segment III of liver. 
E-G. Follow-up portal phase CT image (E) obtained three months after radiofrequency ablation shows collapse (arrows) of previously
seen, thick-walled, cystic lesion at radiofrequency ablation site. However, arterial (left in F) and portal (right in F) phase CT scans
obtained 2.5 cm below (E) demonstrate ill-defined mass (arrows) with thick and irregular low attenuating rim. This lesion shows slight
hyperattenuation on arterial phase (left in F) and slight low attenuation on portal venous (right in F) phase. Therefore, at time of interpre-
tation, tentative radiologic diagnosis was marginal recurrence of hepatocellular carcinoma. Coronal reformatted CT image (G) obtained
during portal venous phase displays mass (arrows) extending exophytically and to extrahepatic portion of mass, which was in contact
with and compressing adjacent stomach (S). Gastroscopy (H) demonstrates 2.5 cm submucosal mass (arrows) at lesser curvature side
of gastric angle. Two small ulcerations (*) observed at center of lesion.
GHThe patient had no subjective symptom and there was no
remarkable finding upon a physical examination. A labora-
tory examination showed a normal range of hemoglobin
level (13.4 g/dL) and platelet count (150,000/μ l), whereas
a decreased WBC count (3,500/μ l) with 55% segmental
neutrophil and 30% lymphocyte was noted. In addition,
mild peripheral eosinophilia (7%) was reported. Liver
function tests were within normal limits and serum α FP
levels showed no increase (1.5 ng/ml) from the previous
test. A gastroscopy revealed a 2.5 cm submucosal mass at
the lesser curvature side of the gastric angle. Small ulcera-
tions were noted at the center of the lesion (Fig. 1H).
A tumorectomy of the liver and distal gastrectomy with
Billroth II anastomosis were performed four months after
performing the RFA. In the operative field, there was a 3×
4 cm-sized mass involving segment III of the liver, which
was adjacent to the stomach. The perioperative diagnosis
also revealed a marginal recurrence of HCC with
suspicious stomach invasion. A cut section of a gross
specimen showed that the mass was primarily located in
the perihepatic fatty tissue and extended to the adjacent
hepatic parenchyma as well as to the proper muscle layer
of the stomach. The area of coagulation necrosis induced
by the previous RFA was pushed upwards by the mass
(Fig. 1I). In addition, there were three openings of fistulous
tract at the mucosa of the adherent stomach. The fistulous
tract communicated with the liver parenchyma. A
microscopic examination revealed relatively hypercellular,
elongated rather than plump spindle cells (myofibroblasts)
and a dense infiltration of inflammatory cells such as
lymphocytes, plasma cells, and eosinophils (Fig. 1J). The
final pathologic diagnosis was an IMT and was sub-catego-
rized as having a compact spindle cell pattern.
The immunohistochemistry results showed positive
results for CD35, CD3, leukocyte common antigen, L26,
Ki67, while the antihepatocyte antigen, desmin, smooth
muscle actin (SMA), anaplastic lymphoma kinase (ALK),
CD34, CD21, and cytokeratin showed a negative result.
The results were consistent with the diagnosis of an IMT.
DISCUSSION
A number of potential complications of an RFA have
been described, occurring with a rate of almost 9% (4).
Complications may be classified into three groups: vascular
(i.e., portal vein thrombosis, hepatic vein thrombosis with
partial hepatic congestion, hepatic infarction, and subcap-
sular hematoma), biliary (i.e., bile duct stenosis, biloma,
abscess, and hemobilia), and extrahepatic (i.e., injury to
the gastrointestinal tract, injury to the gallbladder,
pneumothorax, hemothorax, and tumor seeding) (7).
Theoretically, IMTs could occur as a complication of an
RFA because thermal and mechanical injury caused by
RFA can induce an inflammatory change which was
considered to be one of the causes of developing an IMT.
And as we describe here, IMTs can occur as a complication
Lee et al.
638 Korean J Radiol 10(6), Nov/Dec 2009
Fig. 1. 61-year-old man with 2.3 cm-sized hepatocellular carcinoma in segment III of liver. 
I. Cut section of gross specimen obtained after performing hepatic tumorectomy and distal gastrectomy shows that mass (arrows) was
mainly located in perihepatic fatty tissue (F) and extended to adjacent hepatic parenchyma (L) as well as proper muscle layer (m) of
stomach (S). Area of coagulation necrosis (dotted line) induced by previous radiofrequency ablation was pushed upwards by mass. In
addition, there were three openings of fistulous tract at mucosa of adherent stomach. Moreover, fistulous tract communicated with liver
parenchyma (not shown). 
J. Upon microscopic examination (Hematoxylin & Eosin staining, ×100), elongated spindled myofibroblasts (*) were predominantly seen
with heavy infiltration of lymphocytes and plasma cells. Inflammatory myofibroblastic tumor of compact spindle cell pattern was finally
concluded as diagnosis.
IJof an RFA.
Over the last two decades, IMTs have emerged from the
broad category of inflammatory pseudotumors as a generic
term applied to a variety of neoplastic and non-neoplastic
entities that share a common histologic appearance;
namely spindle cell proliferation with a prominent inflam-
matory infiltrate, with distinctive clinical, pathologic, and
molecular features (8). Even though confusion remains
regarding the distinction of these tumors from other lesions
in the ‘inflammatory pseudotumor’ family, many patholo-
gists recently started to reach a consensus that IMTs should
be separately dealt with as a distinct disease entity because
of the tendency for local recurrence. However, only a
small risk of distant metastasis exists. Histologically, IMTs
are characterized by a variably cellular spindle cell prolif-
eration in a myxoid to collagenous stroma with a
prominent inflammatory infiltrate composed primarily of
plasma cells, and lymphocytes with occasional admixed
eosinophils and neutrophils (8). Coffin et al. (9) described
three basic histologic patterns, which are often seen in
combination within the same tumor: a myxoid/vascular
pattern, a compact spindle cell pattern, and a hypocellular
fibromatosis-like pattern (9). The pathologic examination
of our specimen showed was relatively hypercellular, with
elongated rather than plump spindle cells (myofibroblasts)
and a dense infiltration of inflammatory cells such as
lymphocytes, plasma cells, and eosinophils. As a result the
condition was sub-categorized as a compact spindle cell
pattern.
This is the first case report in the literature describing an
IMT extensively involving the liver, stomach, and perihep-
atic fatty tissue as a possible complication of an RFA. To
find the reason why an IMT may have occurred following
an RFA in our case, we should first consider what the
unique features of our case were. The unique features
might be an injection of artificial ascites and gastric wall
injury with a subsequent gastrohepatic fistula.
Theoretically, there might be a chance to injure the gastro-
hepatic ligament and perihepatic fatty tissue during the
injection of artificial ascites. However, the direct associa-
tion between the injection of ascites and injury could not
be proven. Considering that gastrohepatic fistula can
promote chronic and longstanding inflammation, which is
one of the causes of a developing IMT, we can easily
assume that the presence of a gastrohepatic fistula can be
the possible cause of the occurrence of an IMT in our case.
However, despite several reported cases on various kinds
of fistulas following the RFA, an IMT is a very rare compli-
cation of an RFA. Indeed, even though there were three
case reports describing gastrobiliary (n = 1) or enterobil-
iary (n = 2) fistula as a complication of an RFA, none of
them developed an IMT (10, 11). Although we tried to
minimize gastric injury during the RFA using an artificial
ascites technique (12), we should confess to failing the
prevention of gastric injury because artificial ascites were
not able to remain at the nondependent portion of the
body (i.e., hepatogastric recess), but was re-distributed into
the dependent portion such as in the hepatorenal recess.
Imaging findings of IMTs are variable and usually
nonspecific. The different ratios of cellular infiltration and
hypocellular myxoid or fibrosis components observed
pathologically in an IMT may explain the heterogeneity of
the imaging findings. Because our case was classified as a
pathologic subtype of a compact spindle cell pattern, we
can guess that the imaging findings might resemble those of
a gastrointestinal stromal tumor (GIST). Even though the
dynamic enhancement pattern of a GIST has not yet been
investigated, Kim et al. (13) insisted that most gastric
GISTs show a good or moderate degree of homogeneous
or heterogeneous enhancement on a portal phase CT, as in
our case. However, given that this imaging finding is
nonspecific and there is a previous history of HCC,
reaching such a correct diagnosis for an IMT may be a
difficult preoperative decision to make. 
In a recent article by Lokken et al. (14), benign inflam-
matory nodules occurred in 2% of patients after a percuta-
neous ablation of renal tumors. Despite their rarity, the
occurrence of benign inflammatory nodules are of clinical
importance because they may mimic tumor seeding along
the probe track. Even though the authors have described
imaging features of these inflammatory nodules in detail,
any differential points from tract seeding, aside from the
interval decrease of the lesion size, could not be provided,
which would prompt a biopsy or surgical excision for a
correct diagnosis. Therefore, further investigation using a
sufficient number of cases is strongly warranted in this
regard. 
In conclusion, an IMT can occur as a complication of an
RFA when longstanding inflammation is present, possibly
associated with gastrohepatic fistula formation as observed
in this case. Therefore, radiologists should keep in mind
that an IMT should be included as a differential diagnosis
in patients with a growing mass and as a potential cause
that could lead to longstanding inflammation following an
RFA.
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